Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Change in Cash: 2020-2021

Historic Change in Cash for Design Therapeutics (DSGN) over the last 2 years, with Dec 2021 value amounting to -$59.1 million.

  • Design Therapeutics' Change in Cash fell 6893.25% to -$59.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $296.2 million, marking a year-over-year increase of 12766.64%. This contributed to the annual value of $1.4 million for FY2024, which is 125.72% up from last year.
  • As of Q4 2021, Design Therapeutics' Change in Cash stood at -$59.1 million, which was down 348.49% from -$13.2 million recorded in Q3 2021.
  • Design Therapeutics' 5-year Change in Cash high stood at $398.3 million for Q1 2021, and its period low was -$59.1 million during Q4 2021.
  • Its 2-year average for Change in Cash is $37.3 million, with a median of -$825,500 in 2020.
  • Examining YoY changes over the last 5 years, Design Therapeutics' Change in Cash showed a top increase of 15,073.87% in 2021 and a maximum decrease of 6,893.25% in 2021.
  • Quarterly analysis of 2 years shows Design Therapeutics' Change in Cash stood at -$845,000 in 2020, then tumbled by 6,893.25% to -$59.1 million in 2021.
  • Its last three reported values are -$59.1 million in Q4 2021, -$13.2 million for Q3 2021, and -$29.9 million during Q2 2021.